X0609 4 2026-03-17 1 0001339005 FEMASYS INC FEMY 0001157075 PharmaCyte Biotech, Inc. 3960 HOWARD HUGHES PARKWAY SUITE 500 LAS VEGAS NV 89169 0 0 1 0 0 The Reporting Person's beneficial ownership has fallen below ten percent. As a result, the Reporting Person is no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer and therefore will no longer report any such transactions on Form 4 or Form 5. /s/ Joshua N. Silverman, President and CEO 2026-03-18